nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Carcinoma of lung—Procarbazine—brain cancer	0.0792	0.108	CcSEcCtD
Roflumilast—Lung neoplasm malignant—Procarbazine—brain cancer	0.0684	0.093	CcSEcCtD
Roflumilast—PDE4C—ganglion—brain cancer	0.049	0.185	CbGeAlD
Roflumilast—PDE4C—brainstem—brain cancer	0.0213	0.0806	CbGeAlD
Roflumilast—PDE4C—telencephalon—brain cancer	0.0189	0.0715	CbGeAlD
Roflumilast—PDE4D—telencephalon—brain cancer	0.0166	0.063	CbGeAlD
Roflumilast—PDE4A—telencephalon—brain cancer	0.0147	0.0557	CbGeAlD
Roflumilast—PDE4C—midbrain—brain cancer	0.0136	0.0514	CbGeAlD
Roflumilast—Gynaecomastia—Procarbazine—brain cancer	0.0123	0.0167	CcSEcCtD
Roflumilast—PDE4C—head—brain cancer	0.0118	0.0445	CbGeAlD
Roflumilast—PDE4C—central nervous system—brain cancer	0.0107	0.0407	CbGeAlD
Roflumilast—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.0101	0.0137	CcSEcCtD
Roflumilast—Endocrine disorder—Temozolomide—brain cancer	0.01	0.0136	CcSEcCtD
Roflumilast—PDE4D—cerebellum—brain cancer	0.00924	0.035	CbGeAlD
Roflumilast—PDE4B—telencephalon—brain cancer	0.00878	0.0332	CbGeAlD
Roflumilast—Infection—Carboplatin—brain cancer	0.00876	0.0119	CcSEcCtD
Roflumilast—PDE4C—brain—brain cancer	0.00853	0.0323	CbGeAlD
Roflumilast—Renal failure acute—Hydroxyurea—brain cancer	0.00835	0.0114	CcSEcCtD
Roflumilast—PDE4A—cerebellum—brain cancer	0.00818	0.031	CbGeAlD
Roflumilast—Pneumonia—Procarbazine—brain cancer	0.00772	0.0105	CcSEcCtD
Roflumilast—Gynaecomastia—Carmustine—brain cancer	0.00769	0.0104	CcSEcCtD
Roflumilast—Infection—Lomustine—brain cancer	0.00766	0.0104	CcSEcCtD
Roflumilast—PDE4D—brain—brain cancer	0.00751	0.0284	CbGeAlD
Roflumilast—PDE4B—gonad—brain cancer	0.00733	0.0277	CbGeAlD
Roflumilast—PDE4B—pituitary gland—brain cancer	0.00715	0.0271	CbGeAlD
Roflumilast—PDE4B—medulla oblongata—brain cancer	0.0069	0.0261	CbGeAlD
Roflumilast—Decreased appetite—Lomustine—brain cancer	0.00671	0.00911	CcSEcCtD
Roflumilast—PDE4A—brain—brain cancer	0.00664	0.0251	CbGeAlD
Roflumilast—PDE4B—midbrain—brain cancer	0.0063	0.0239	CbGeAlD
Roflumilast—PDE4B—spinal cord—brain cancer	0.00615	0.0233	CbGeAlD
Roflumilast—Infestation NOS—Hydroxyurea—brain cancer	0.00594	0.00808	CcSEcCtD
Roflumilast—Infestation—Hydroxyurea—brain cancer	0.00594	0.00808	CcSEcCtD
Roflumilast—Tension—Procarbazine—brain cancer	0.00589	0.008	CcSEcCtD
Roflumilast—Nervousness—Procarbazine—brain cancer	0.00583	0.00792	CcSEcCtD
Roflumilast—Tremor—Procarbazine—brain cancer	0.00562	0.00764	CcSEcCtD
Roflumilast—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00562	0.00764	CcSEcCtD
Roflumilast—PDE4B—endocrine gland—brain cancer	0.00554	0.021	CbGeAlD
Roflumilast—PDE4B—head—brain cancer	0.00547	0.0207	CbGeAlD
Roflumilast—Myalgia—Procarbazine—brain cancer	0.00511	0.00694	CcSEcCtD
Roflumilast—Anxiety—Procarbazine—brain cancer	0.00509	0.00692	CcSEcCtD
Roflumilast—PDE4B—central nervous system—brain cancer	0.00499	0.0189	CbGeAlD
Roflumilast—Vomiting—Lomustine—brain cancer	0.00491	0.00667	CcSEcCtD
Roflumilast—PDE4B—cerebellum—brain cancer	0.00488	0.0185	CbGeAlD
Roflumilast—Infection—Procarbazine—brain cancer	0.00487	0.00661	CcSEcCtD
Roflumilast—Pneumonia—Carmustine—brain cancer	0.00483	0.00657	CcSEcCtD
Roflumilast—Depression—Carmustine—brain cancer	0.00479	0.00651	CcSEcCtD
Roflumilast—Weight decreased—Temozolomide—brain cancer	0.00471	0.0064	CcSEcCtD
Roflumilast—Urinary tract infection—Carmustine—brain cancer	0.00467	0.00635	CcSEcCtD
Roflumilast—Pneumonia—Temozolomide—brain cancer	0.00467	0.00635	CcSEcCtD
Roflumilast—Infestation NOS—Temozolomide—brain cancer	0.00464	0.00631	CcSEcCtD
Roflumilast—Infestation—Temozolomide—brain cancer	0.00464	0.00631	CcSEcCtD
Roflumilast—Depression—Temozolomide—brain cancer	0.00463	0.00629	CcSEcCtD
Roflumilast—Nausea—Lomustine—brain cancer	0.00458	0.00623	CcSEcCtD
Roflumilast—Urinary tract infection—Temozolomide—brain cancer	0.00451	0.00613	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00446	0.00606	CcSEcCtD
Roflumilast—Insomnia—Procarbazine—brain cancer	0.00443	0.00602	CcSEcCtD
Roflumilast—Hepatobiliary disease—Temozolomide—brain cancer	0.00439	0.00597	CcSEcCtD
Roflumilast—Sinusitis—Temozolomide—brain cancer	0.00436	0.00592	CcSEcCtD
Roflumilast—Ill-defined disorder—Hydroxyurea—brain cancer	0.00431	0.00586	CcSEcCtD
Roflumilast—Decreased appetite—Procarbazine—brain cancer	0.00426	0.00579	CcSEcCtD
Roflumilast—Connective tissue disorder—Carmustine—brain cancer	0.00424	0.00576	CcSEcCtD
Roflumilast—Fatigue—Procarbazine—brain cancer	0.00422	0.00574	CcSEcCtD
Roflumilast—Malaise—Hydroxyurea—brain cancer	0.00419	0.00569	CcSEcCtD
Roflumilast—Constipation—Procarbazine—brain cancer	0.00419	0.00569	CcSEcCtD
Roflumilast—Connective tissue disorder—Temozolomide—brain cancer	0.0041	0.00557	CcSEcCtD
Roflumilast—Feeling abnormal—Procarbazine—brain cancer	0.00404	0.00549	CcSEcCtD
Roflumilast—Gastrointestinal pain—Procarbazine—brain cancer	0.00401	0.00544	CcSEcCtD
Roflumilast—PDE4B—brain—brain cancer	0.00396	0.015	CbGeAlD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00393	0.00534	CcSEcCtD
Roflumilast—Discomfort—Hydroxyurea—brain cancer	0.00391	0.00531	CcSEcCtD
Roflumilast—Urticaria—Procarbazine—brain cancer	0.00389	0.00529	CcSEcCtD
Roflumilast—Abdominal pain—Procarbazine—brain cancer	0.00387	0.00526	CcSEcCtD
Roflumilast—Cardiac disorder—Temozolomide—brain cancer	0.00387	0.00526	CcSEcCtD
Roflumilast—Mental disorder—Carmustine—brain cancer	0.00378	0.00514	CcSEcCtD
Roflumilast—Infection—Hydroxyurea—brain cancer	0.00377	0.00512	CcSEcCtD
Roflumilast—Immune system disorder—Temozolomide—brain cancer	0.00377	0.00512	CcSEcCtD
Roflumilast—Mediastinal disorder—Temozolomide—brain cancer	0.00376	0.00511	CcSEcCtD
Roflumilast—Malnutrition—Carmustine—brain cancer	0.00375	0.0051	CcSEcCtD
Roflumilast—Pneumonia—Etoposide—brain cancer	0.00374	0.00508	CcSEcCtD
Roflumilast—Nervous system disorder—Hydroxyurea—brain cancer	0.00372	0.00505	CcSEcCtD
Roflumilast—Infestation—Etoposide—brain cancer	0.00372	0.00505	CcSEcCtD
Roflumilast—Infestation NOS—Etoposide—brain cancer	0.00372	0.00505	CcSEcCtD
Roflumilast—Skin disorder—Hydroxyurea—brain cancer	0.00368	0.005	CcSEcCtD
Roflumilast—Mental disorder—Temozolomide—brain cancer	0.00365	0.00496	CcSEcCtD
Roflumilast—Back pain—Carmustine—brain cancer	0.00363	0.00494	CcSEcCtD
Roflumilast—Malnutrition—Temozolomide—brain cancer	0.00363	0.00493	CcSEcCtD
Roflumilast—Hypersensitivity—Procarbazine—brain cancer	0.00361	0.0049	CcSEcCtD
Roflumilast—Dysgeusia—Temozolomide—brain cancer	0.00355	0.00483	CcSEcCtD
Roflumilast—Tremor—Carmustine—brain cancer	0.00352	0.00478	CcSEcCtD
Roflumilast—Asthenia—Procarbazine—brain cancer	0.00351	0.00478	CcSEcCtD
Roflumilast—Hepatobiliary disease—Etoposide—brain cancer	0.00351	0.00478	CcSEcCtD
Roflumilast—Back pain—Temozolomide—brain cancer	0.00351	0.00477	CcSEcCtD
Roflumilast—Tremor—Temozolomide—brain cancer	0.0034	0.00462	CcSEcCtD
Roflumilast—Ill-defined disorder—Temozolomide—brain cancer	0.00337	0.00458	CcSEcCtD
Roflumilast—Diarrhoea—Procarbazine—brain cancer	0.00335	0.00455	CcSEcCtD
Roflumilast—Dyspepsia—Hydroxyurea—brain cancer	0.00334	0.00453	CcSEcCtD
Roflumilast—Angioedema—Temozolomide—brain cancer	0.00332	0.00451	CcSEcCtD
Roflumilast—Decreased appetite—Hydroxyurea—brain cancer	0.0033	0.00448	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00327	0.00445	CcSEcCtD
Roflumilast—Malaise—Temozolomide—brain cancer	0.00327	0.00445	CcSEcCtD
Roflumilast—Fatigue—Hydroxyurea—brain cancer	0.00327	0.00444	CcSEcCtD
Roflumilast—Vertigo—Temozolomide—brain cancer	0.00326	0.00443	CcSEcCtD
Roflumilast—Constipation—Hydroxyurea—brain cancer	0.00324	0.00441	CcSEcCtD
Roflumilast—Dizziness—Procarbazine—brain cancer	0.00324	0.0044	CcSEcCtD
Roflumilast—Palpitations—Temozolomide—brain cancer	0.00321	0.00436	CcSEcCtD
Roflumilast—Myalgia—Carmustine—brain cancer	0.0032	0.00434	CcSEcCtD
Roflumilast—Anxiety—Carmustine—brain cancer	0.00319	0.00433	CcSEcCtD
Roflumilast—Feeling abnormal—Hydroxyurea—brain cancer	0.00312	0.00425	CcSEcCtD
Roflumilast—Vomiting—Procarbazine—brain cancer	0.00311	0.00423	CcSEcCtD
Roflumilast—Cardiac disorder—Etoposide—brain cancer	0.0031	0.00421	CcSEcCtD
Roflumilast—Myalgia—Temozolomide—brain cancer	0.00309	0.0042	CcSEcCtD
Roflumilast—Rash—Procarbazine—brain cancer	0.00309	0.0042	CcSEcCtD
Roflumilast—Dermatitis—Procarbazine—brain cancer	0.00309	0.00419	CcSEcCtD
Roflumilast—Anxiety—Temozolomide—brain cancer	0.00308	0.00418	CcSEcCtD
Roflumilast—Headache—Procarbazine—brain cancer	0.00307	0.00417	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00307	0.00417	CcSEcCtD
Roflumilast—Discomfort—Temozolomide—brain cancer	0.00305	0.00415	CcSEcCtD
Roflumilast—Infection—Carmustine—brain cancer	0.00304	0.00414	CcSEcCtD
Roflumilast—Immune system disorder—Etoposide—brain cancer	0.00301	0.00409	CcSEcCtD
Roflumilast—Mediastinal disorder—Etoposide—brain cancer	0.00301	0.00409	CcSEcCtD
Roflumilast—Infection—Temozolomide—brain cancer	0.00294	0.004	CcSEcCtD
Roflumilast—Nausea—Procarbazine—brain cancer	0.00291	0.00395	CcSEcCtD
Roflumilast—Nervous system disorder—Temozolomide—brain cancer	0.0029	0.00395	CcSEcCtD
Roflumilast—Skin disorder—Temozolomide—brain cancer	0.00288	0.00391	CcSEcCtD
Roflumilast—Dysgeusia—Etoposide—brain cancer	0.00284	0.00386	CcSEcCtD
Roflumilast—Back pain—Etoposide—brain cancer	0.00281	0.00382	CcSEcCtD
Roflumilast—Hypersensitivity—Hydroxyurea—brain cancer	0.00279	0.0038	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Carmustine—brain cancer	0.00279	0.00379	CcSEcCtD
Roflumilast—Muscle spasms—Etoposide—brain cancer	0.00279	0.00379	CcSEcCtD
Roflumilast—Insomnia—Carmustine—brain cancer	0.00277	0.00377	CcSEcCtD
Roflumilast—Asthenia—Hydroxyurea—brain cancer	0.00272	0.0037	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Temozolomide—brain cancer	0.0027	0.00367	CcSEcCtD
Roflumilast—Ill-defined disorder—Etoposide—brain cancer	0.00269	0.00366	CcSEcCtD
Roflumilast—Insomnia—Temozolomide—brain cancer	0.00268	0.00364	CcSEcCtD
Roflumilast—Decreased appetite—Carmustine—brain cancer	0.00266	0.00362	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Carmustine—brain cancer	0.00265	0.0036	CcSEcCtD
Roflumilast—Constipation—Carmustine—brain cancer	0.00262	0.00356	CcSEcCtD
Roflumilast—Malaise—Etoposide—brain cancer	0.00262	0.00356	CcSEcCtD
Roflumilast—Vertigo—Etoposide—brain cancer	0.00261	0.00355	CcSEcCtD
Roflumilast—Dyspepsia—Temozolomide—brain cancer	0.00261	0.00354	CcSEcCtD
Roflumilast—Diarrhoea—Hydroxyurea—brain cancer	0.00259	0.00352	CcSEcCtD
Roflumilast—Decreased appetite—Temozolomide—brain cancer	0.00257	0.0035	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Temozolomide—brain cancer	0.00256	0.00347	CcSEcCtD
Roflumilast—Fatigue—Temozolomide—brain cancer	0.00255	0.00347	CcSEcCtD
Roflumilast—Constipation—Temozolomide—brain cancer	0.00253	0.00344	CcSEcCtD
Roflumilast—Feeling abnormal—Carmustine—brain cancer	0.00253	0.00343	CcSEcCtD
Roflumilast—Dizziness—Hydroxyurea—brain cancer	0.00251	0.00341	CcSEcCtD
Roflumilast—Gastrointestinal pain—Carmustine—brain cancer	0.00251	0.00341	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00245	0.00334	CcSEcCtD
Roflumilast—Discomfort—Etoposide—brain cancer	0.00244	0.00332	CcSEcCtD
Roflumilast—Feeling abnormal—Temozolomide—brain cancer	0.00244	0.00332	CcSEcCtD
Roflumilast—Abdominal pain—Carmustine—brain cancer	0.00242	0.00329	CcSEcCtD
Roflumilast—Gastrointestinal pain—Temozolomide—brain cancer	0.00242	0.00329	CcSEcCtD
Roflumilast—Vomiting—Hydroxyurea—brain cancer	0.00241	0.00328	CcSEcCtD
Roflumilast—Rash—Hydroxyurea—brain cancer	0.00239	0.00325	CcSEcCtD
Roflumilast—Dermatitis—Hydroxyurea—brain cancer	0.00239	0.00325	CcSEcCtD
Roflumilast—Headache—Hydroxyurea—brain cancer	0.00237	0.00323	CcSEcCtD
Roflumilast—Infection—Etoposide—brain cancer	0.00235	0.0032	CcSEcCtD
Roflumilast—Urticaria—Temozolomide—brain cancer	0.00235	0.0032	CcSEcCtD
Roflumilast—Abdominal pain—Temozolomide—brain cancer	0.00234	0.00318	CcSEcCtD
Roflumilast—Skin disorder—Etoposide—brain cancer	0.0023	0.00313	CcSEcCtD
Roflumilast—Hypersensitivity—Carmustine—brain cancer	0.00226	0.00307	CcSEcCtD
Roflumilast—Nausea—Hydroxyurea—brain cancer	0.00225	0.00306	CcSEcCtD
Roflumilast—Asthenia—Carmustine—brain cancer	0.0022	0.00299	CcSEcCtD
Roflumilast—Hypersensitivity—Temozolomide—brain cancer	0.00218	0.00297	CcSEcCtD
Roflumilast—Asthenia—Temozolomide—brain cancer	0.00212	0.00289	CcSEcCtD
Roflumilast—Diarrhoea—Carmustine—brain cancer	0.0021	0.00285	CcSEcCtD
Roflumilast—Decreased appetite—Etoposide—brain cancer	0.00206	0.0028	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Etoposide—brain cancer	0.00205	0.00278	CcSEcCtD
Roflumilast—Fatigue—Etoposide—brain cancer	0.00204	0.00278	CcSEcCtD
Roflumilast—Dizziness—Carmustine—brain cancer	0.00203	0.00275	CcSEcCtD
Roflumilast—Constipation—Etoposide—brain cancer	0.00203	0.00275	CcSEcCtD
Roflumilast—Diarrhoea—Temozolomide—brain cancer	0.00203	0.00275	CcSEcCtD
Roflumilast—Dizziness—Temozolomide—brain cancer	0.00196	0.00266	CcSEcCtD
Roflumilast—Feeling abnormal—Etoposide—brain cancer	0.00195	0.00265	CcSEcCtD
Roflumilast—Vomiting—Carmustine—brain cancer	0.00195	0.00265	CcSEcCtD
Roflumilast—Gastrointestinal pain—Etoposide—brain cancer	0.00194	0.00263	CcSEcCtD
Roflumilast—Rash—Carmustine—brain cancer	0.00193	0.00263	CcSEcCtD
Roflumilast—Dermatitis—Carmustine—brain cancer	0.00193	0.00262	CcSEcCtD
Roflumilast—Headache—Carmustine—brain cancer	0.00192	0.00261	CcSEcCtD
Roflumilast—Vomiting—Temozolomide—brain cancer	0.00188	0.00256	CcSEcCtD
Roflumilast—Urticaria—Etoposide—brain cancer	0.00188	0.00256	CcSEcCtD
Roflumilast—Abdominal pain—Etoposide—brain cancer	0.00187	0.00255	CcSEcCtD
Roflumilast—Rash—Temozolomide—brain cancer	0.00187	0.00254	CcSEcCtD
Roflumilast—Dermatitis—Temozolomide—brain cancer	0.00187	0.00254	CcSEcCtD
Roflumilast—Headache—Temozolomide—brain cancer	0.00186	0.00252	CcSEcCtD
Roflumilast—Nausea—Carmustine—brain cancer	0.00182	0.00247	CcSEcCtD
Roflumilast—Nausea—Temozolomide—brain cancer	0.00176	0.00239	CcSEcCtD
Roflumilast—Hypersensitivity—Etoposide—brain cancer	0.00175	0.00237	CcSEcCtD
Roflumilast—Asthenia—Etoposide—brain cancer	0.0017	0.00231	CcSEcCtD
Roflumilast—Diarrhoea—Etoposide—brain cancer	0.00162	0.0022	CcSEcCtD
Roflumilast—Dizziness—Etoposide—brain cancer	0.00157	0.00213	CcSEcCtD
Roflumilast—Vomiting—Etoposide—brain cancer	0.00151	0.00205	CcSEcCtD
Roflumilast—Rash—Etoposide—brain cancer	0.00149	0.00203	CcSEcCtD
Roflumilast—Dermatitis—Etoposide—brain cancer	0.00149	0.00203	CcSEcCtD
Roflumilast—Headache—Etoposide—brain cancer	0.00148	0.00202	CcSEcCtD
Roflumilast—Nausea—Etoposide—brain cancer	0.00141	0.00191	CcSEcCtD
